Outcomes Of The TOURMALINE-MM3 Study

Peter Vorhees, MD, Director of Outreach and Clinical Operations, Department of Hematologic Oncology and Blood Diosrders, Levine Cancer Institute, discusses Outcomes Of The TOURMALINE-MM3 Study. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com